Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Clinical Oncology Next Generation Sequencing (NGS)
1.2 Key Market Segments
1.2.1 Clinical Oncology Next Generation Sequencing (NGS) Segment by Type
1.2.2 Clinical Oncology Next Generation Sequencing (NGS) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Clinical Oncology Next Generation Sequencing (NGS) Market Overview
2.1 Global Market Overview
2.1.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Clinical Oncology Next Generation Sequencing (NGS) Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Clinical Oncology Next Generation Sequencing (NGS) Market Competitive Landscape
3.1 Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Manufacturers (2019-2025)
3.2 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Manufacturers (2019-2025)
3.3 Clinical Oncology Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Clinical Oncology Next Generation Sequencing (NGS) Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Clinical Oncology Next Generation Sequencing (NGS) Sales Sites, Area Served, Product Type
3.6 Clinical Oncology Next Generation Sequencing (NGS) Market Competitive Situation and Trends
3.6.1 Clinical Oncology Next Generation Sequencing (NGS) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Clinical Oncology Next Generation Sequencing (NGS) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Clinical Oncology Next Generation Sequencing (NGS) Industry Chain Analysis
4.1 Clinical Oncology Next Generation Sequencing (NGS) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Clinical Oncology Next Generation Sequencing (NGS) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Clinical Oncology Next Generation Sequencing (NGS) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Type (2019-2025)
6.3 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2019-2025)
6.4 Global Clinical Oncology Next Generation Sequencing (NGS) Price by Type (2019-2025)
7 Clinical Oncology Next Generation Sequencing (NGS) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Sales by Application (2019-2025)
7.3 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD) by Application (2019-2025)
7.4 Global Clinical Oncology Next Generation Sequencing (NGS) Sales Growth Rate by Application (2019-2025)
8 Clinical Oncology Next Generation Sequencing (NGS) Market Consumption by Region
8.1 Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Region
8.1.1 Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Region
8.1.2 Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Region
8.2 North America
8.2.1 North America Clinical Oncology Next Generation Sequencing (NGS) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Clinical Oncology Next Generation Sequencing (NGS) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Clinical Oncology Next Generation Sequencing (NGS) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Clinical Oncology Next Generation Sequencing (NGS) Market Production by Region
9.1 Global Production of Clinical Oncology Next Generation Sequencing (NGS) by Region (2019-2025)
9.2 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Region (2019-2025)
9.3 Global Clinical Oncology Next Generation Sequencing (NGS) Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Clinical Oncology Next Generation Sequencing (NGS) Production
9.4.1 North America Clinical Oncology Next Generation Sequencing (NGS) Production Growth Rate (2019-2025)
9.4.2 North America Clinical Oncology Next Generation Sequencing (NGS) Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Clinical Oncology Next Generation Sequencing (NGS) Production
9.5.1 Europe Clinical Oncology Next Generation Sequencing (NGS) Production Growth Rate (2019-2025)
9.5.2 Europe Clinical Oncology Next Generation Sequencing (NGS) Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Clinical Oncology Next Generation Sequencing (NGS) Production (2019-2025)
9.6.1 Japan Clinical Oncology Next Generation Sequencing (NGS) Production Growth Rate (2019-2025)
9.6.2 Japan Clinical Oncology Next Generation Sequencing (NGS) Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Clinical Oncology Next Generation Sequencing (NGS) Production (2019-2025)
9.7.1 China Clinical Oncology Next Generation Sequencing (NGS) Production Growth Rate (2019-2025)
9.7.2 China Clinical Oncology Next Generation Sequencing (NGS) Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Illumina
10.1.1 Illumina Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.1.2 Illumina Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.1.3 Illumina Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.1.4 Illumina Business Overview
10.1.5 Illumina Clinical Oncology Next Generation Sequencing (NGS) SWOT Analysis
10.1.6 Illumina Recent Developments
10.2 Roche
10.2.1 Roche Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.2.2 Roche Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.2.3 Roche Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.2.4 Roche Business Overview
10.2.5 Roche Clinical Oncology Next Generation Sequencing (NGS) SWOT Analysis
10.2.6 Roche Recent Developments
10.3 Agilent Technologies
10.3.1 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.3.2 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.3.3 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.3.4 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) SWOT Analysis
10.3.5 Agilent Technologies Business Overview
10.3.6 Agilent Technologies Recent Developments
10.4 Knome
10.4.1 Knome Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.4.2 Knome Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.4.3 Knome Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.4.4 Knome Business Overview
10.4.5 Knome Recent Developments
10.5 Genomatix Software
10.5.1 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.5.2 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.5.3 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.5.4 Genomatix Software Business Overview
10.5.5 Genomatix Software Recent Developments
10.6 GATC Biotech
10.6.1 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.6.2 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.6.3 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.6.4 GATC Biotech Business Overview
10.6.5 GATC Biotech Recent Developments
10.7 Oxford Nanopore Technologies
10.7.1 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.7.2 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.7.3 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.7.4 Oxford Nanopore Technologies Business Overview
10.7.5 Oxford Nanopore Technologies Recent Developments
10.8 Macrogen
10.8.1 Macrogen Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.8.2 Macrogen Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.8.3 Macrogen Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.8.4 Macrogen Business Overview
10.8.5 Macrogen Recent Developments
10.9 Life Technologies
10.9.1 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.9.2 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.9.3 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.9.4 Life Technologies Business Overview
10.9.5 Life Technologies Recent Developments
10.10 DNASTAR
10.10.1 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.10.2 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.10.3 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.10.4 DNASTAR Business Overview
10.10.5 DNASTAR Recent Developments
10.11 Exosome Diagnostics
10.11.1 Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.11.2 Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.11.3 Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.11.4 Exosome Diagnostics Business Overview
10.11.5 Exosome Diagnostics Recent Developments
10.12 Biomatters
10.12.1 Biomatters Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.12.2 Biomatters Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.12.3 Biomatters Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.12.4 Biomatters Business Overview
10.12.5 Biomatters Recent Developments
10.13 CLC Bio
10.13.1 CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.13.2 CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.13.3 CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.13.4 CLC Bio Business Overview
10.13.5 CLC Bio Recent Developments
10.14 BGI
10.14.1 BGI Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.14.2 BGI Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.14.3 BGI Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.14.4 BGI Business Overview
10.14.5 BGI Recent Developments
10.15 Qiagen
10.15.1 Qiagen Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.15.2 Qiagen Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.15.3 Qiagen Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.15.4 Qiagen Business Overview
10.15.5 Qiagen Recent Developments
10.16 Perkin Elmer
10.16.1 Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.16.2 Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.16.3 Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.16.4 Perkin Elmer Business Overview
10.16.5 Perkin Elmer Recent Developments
10.17 Pacific Bioscience
10.17.1 Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.17.2 Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.17.3 Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.17.4 Pacific Bioscience Business Overview
10.17.5 Pacific Bioscience Recent Developments
10.18 Partek
10.18.1 Partek Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.18.2 Partek Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.18.3 Partek Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.18.4 Partek Business Overview
10.18.5 Partek Recent Developments
10.19 GnuBIO
10.19.1 GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.19.2 GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.19.3 GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.19.4 GnuBIO Business Overview
10.19.5 GnuBIO Recent Developments
10.20 Foundation Medicine
10.20.1 Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.20.2 Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.20.3 Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.20.4 Foundation Medicine Business Overview
10.20.5 Foundation Medicine Recent Developments
10.21 Paradigm
10.21.1 Paradigm Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.21.2 Paradigm Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.21.3 Paradigm Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.21.4 Paradigm Business Overview
10.21.5 Paradigm Recent Developments
10.22 Caris Life Sciences
10.22.1 Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.22.2 Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.22.3 Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.22.4 Caris Life Sciences Business Overview
10.22.5 Caris Life Sciences Recent Developments
10.23 Myriad Genetics
10.23.1 Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.23.2 Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.23.3 Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.23.4 Myriad Genetics Business Overview
10.23.5 Myriad Genetics Recent Developments
11 Clinical Oncology Next Generation Sequencing (NGS) Market Forecast by Region
11.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast
11.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Country
11.2.3 Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Region
11.2.4 South America Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Clinical Oncology Next Generation Sequencing (NGS) by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Clinical Oncology Next Generation Sequencing (NGS) by Type (2025-2032)
12.1.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Clinical Oncology Next Generation Sequencing (NGS) by Type (2025-2032)
12.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Forecast by Application (2025-2032)
12.2.1 Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) Forecast by Application
12.2.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
